IL17A and colorectal carcinoma: CD4+ Th17 immune cells are the main source of IL-17A in CRC tumors and adjacent tissues (134, 135); yet, CD8+ T cell subsets, γδ T cells, and innate lymphoid cells (ILCs) are also important producers of IL-17A (136–139).